StockData
Bausch Health Companies Inc. logo

Bausch Health Companies Inc. (BHC) stock

BHCNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 8/3077% below fair value
$8.47+0.05 (+0.59%)

Close on Nov 17, 2026Market cap $3.17BP/E –Yield –

Bausch Health Companies cash

Cash and short-term investments held at the end of each period.

Bausch Health Companies's cash was $2.49B at Sep 30, 2026. For fiscal 2025 it was $1.31B, up 9.0% from the year before. Over ten years it grew 8.2% a year on average. The highest annual figure on record is $3.24B in fiscal 2019.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$1.31B+9.0%
FY2024Dec 31, 2024$1.20B+26.8%
FY2023Dec 31, 2023$947.00M+60.2%
FY2022Dec 31, 2022$591.00M-72.1%
FY2021Dec 31, 2021$2.12B+16.7%
FY2020Dec 31, 2020$1.82B-44.0%
FY2019Dec 31, 2019$3.24B+349.9%
FY2018Dec 31, 2018$721.00M-9.5%
FY2017Dec 31, 2017$797.00M+47.0%
FY2016Dec 31, 2016$542.00M-9.2%
FY2015Dec 31, 2015$597.00M+84.8%
FY2014Dec 31, 2014$323.00M-46.2%
FY2013Dec 31, 2013$600.00M-34.8%
FY2012Dec 31, 2012$920.51M+440.1%
FY2011Dec 31, 2011$170.44M-57.4%
FY2010Dec 31, 2010$400.35M+222.8%
FY2009Dec 31, 2009$124.03M-60.9%
FY2008Dec 31, 2008$317.55M-26.8%
FY2007Dec 31, 2007$433.64M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$2.49B+90.0%
Q2 FY2026Jun 30, 2026$1.83B+5.7%
Q1 FY2026Mar 31, 2026$1.30B+14.6%
Q4 FY2025Dec 31, 2025$1.31B+9.0%
Q3 FY2025Sep 30, 2025$1.31B+81.9%
Q2 FY2025Jun 30, 2025$1.73B+190.3%
Q1 FY2025Mar 31, 2025$1.13B+54.7%
Q4 FY2024Dec 31, 2024$1.20B+26.8%
Q3 FY2024Sep 30, 2024$719.00M-5.4%
Q2 FY2024Jun 30, 2024$595.00M+2.8%
Q1 FY2024Mar 31, 2024$733.00M+41.5%
Q4 FY2023Dec 31, 2023$947.00M+60.2%
Q3 FY2023Sep 30, 2023$760.00M+56.4%
Q2 FY2023Jun 30, 2023$579.00M-12.1%
Q1 FY2023Mar 31, 2023$518.00M-58.5%
Q4 FY2022Dec 31, 2022$591.00M-72.1%
Q3 FY2022Sep 30, 2022$486.00M-29.6%
Q2 FY2022Jun 30, 2022$659.00M+2.6%
Q1 FY2022Mar 31, 2022$1.25B+83.9%
Q4 FY2021Dec 31, 2021$2.12B+16.7%
Q3 FY2021Sep 30, 2021$690.00M-29.4%
Q2 FY2021Jun 30, 2021$642.00M-28.3%
Q1 FY2021Mar 31, 2021$679.00M-25.5%
Q4 FY2020Dec 31, 2020$1.82B-44.0%
Q3 FY2020Sep 30, 2020$977.00M+18.4%
Q2 FY2020Jun 30, 2020$896.00M+2.1%
Q1 FY2020Mar 31, 2020$912.00M+16.6%
Q4 FY2019Dec 31, 2019$3.24B+349.9%
Q3 FY2019Sep 30, 2019$825.00M-15.2%
Q2 FY2019Jun 30, 2019$878.00M+4.8%
Q1 FY2019Mar 31, 2019$782.00M-14.0%
Q4 FY2018Dec 31, 2018$721.00M-9.5%
Q3 FY2018Sep 30, 2018$973.00M+0.9%
Q2 FY2018Jun 30, 2018$838.00M-31.0%
Q1 FY2018Mar 31, 2018$909.00M-24.9%
Q4 FY2017Dec 31, 2017$797.00M+47.0%
Q3 FY2017Sep 30, 2017$964.00M–
Q2 FY2017Jun 30, 2017$1.21B–
Q1 FY2017Mar 31, 2017$1.21B–
Q4 FY2016Dec 31, 2016$542.00M–

More Bausch Health Companies figures

See a number that looks wrong?